
Customize View
Recently disclosed strategic alliances only (within the last two years)
Include Strategic Alliances for:Current subsidiaries



Strategic Alliances

Recently Disclosed Strategic Alliances
Strategic Alliance Name
Primary Industry
Source
I-Mab Biopharma (Shanghai) Co., Ltd.
Biotechnology
Key DevelopmentStrategic Alliances Apr-08-2019
Business Description: I-Mab Biopharma (Shanghai) Co., Ltd., a biopharmaceutical company, discovers, develops, and commercializes medicines for immuno-oncology and immuno-inflammation. It develops drugs for various therapeutic areas, including multiple myeloma/autoimmune diseases, pediatric growth, hormone deficiency, ulcerative colitis, head and neck cancer/oncology, oncology-related lymphopenia, cytokine release syndrome, and multiple cancer indications. I-Mab Biopharma (Shanghai) Co., Ltd. was founded in 2016 and is headquartered in Shanghai, China. It has additional offices in Beijing, China; and Rockville, Maryland. I-Mab Biopharma (Shanghai) Co., Ltd. operates as a subsidiary of I-Mab.
*denotes proprietary relationship